|
|
Post by savzak on Aug 11, 2014 14:10:59 GMT -5
This is in the "wishful thinking" department. Perhaps MannKind has one or more Technosphere deals pretty much ready to execute that they've been holding back just in case they needed Technosphere for some aspect of the big partnership deal. If that's the case, MannKind could finalize those deals in short order. Of course, past experience tells us they probably wouldn't move the stock price anyway.  |
|
|
|
Post by bradleysbest on Aug 11, 2014 14:12:42 GMT -5
True! Nothing seems to move the price up.....
|
|
|
|
Post by 4Balance on Aug 11, 2014 14:13:28 GMT -5
Savzak,
Deals? I know they've wanted to pursue migraine therapy, and have had to push some cancer studies to the back burner in order to bring Afrezza to this point. Did you have anything particular in mind....??
|
|
|
|
Post by bradleysbest on Aug 11, 2014 14:19:09 GMT -5
At the shareholder meeting in May, Al specifically mentioned inhalable migraine treatments. He said his wife suffers migraines.
|
|
|
|
Post by savzak on Aug 11, 2014 14:22:57 GMT -5
4balance, it could be the opportunities you've mentioned or any number of other possibilities. These deals would not necessarily be all that big in terms of cash up front, but they would begin to show that the pharma community recognizes the potential of technosphere.
|
|
|
|
Post by 4Balance on Aug 11, 2014 14:23:08 GMT -5
I suspect that a migraine trial might be less complex than a cancer trial.
Furthermore...what's a loving husband to do...??!
|
|
|
|
Post by ashiwi on Aug 11, 2014 14:35:30 GMT -5
MNKD can recruit it's own shareholders for the Migraine trial.
The way this stock has been trading, I bet there are plenty of us with migraines.
|
|
